Capital Fund Management S.A. Veracyte, Inc. Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $641,810 - $1.26 Million	-41,921 Reduced 57.38%	31,141 $738,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $499,787 - $841,017	30,144 Added 70.24%	73,062 $1.21 Billion
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $663,083 - $1.27 Million	42,918 New	42,918 $854,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $332,529 - $571,578	-10,095 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $448,924 - $821,531	10,095 New	10,095 $542,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.